The capacity of E1A gene-deleted and thus replicationdefective adenovirus type 5 (Ad5) to transduce foreign genes in chicken embryo fibroblasts (CEF) as well as in chickens was investigated. The lacZ and luciferase genes were successfully transduced in CEF by replicationdefective Ad5, demonstrating that these cells possess receptor(s) for binding and penetration of Ad5. A single intramuscular inoculation of Ad-gD, a replicationdefective Ad5 harbouring the gD gene of pseudorabies virus, in adult and 1-day-old chickens led to the production of very high titres of specific antibodies. These gD-specific antibodies persisted for at least 56 days. These results demonstrate that replication-defective Ad5, despite its mammalian origin and the deletion of the EIA gene, is a good candidate for developing non-spreading vaccines in poultry.Until recently, in contrast to mammalian species, fewer efforts have been made to develop recombinant virusvectored vaccines for avian species. Among poxvirusbased vectors, fowlpox and vaccinia viruses expressing the haemagglutin or the neuraminidase antigens have been shown to protect chickens against influenza (Boursnell et al., 1990; Chambers et al., 1988;Webster et al., 1991). Fowlpox virus recombinants expressing proteins from Marek's disease virus have also been developed (Yanagida et al., 1992). A pigeonpox virus expressing the fusion glycoprotein of Newcastle disease virus (NDV) was able to protect chickens against NDV challenge (Letellier et aL, 1991). Herpesviruses (infectious laryngotracheitis virus and herpesvirus of turkeys) are also being developed as virus vectors (Morgan et al., 1992;Sondermeijer et al., 1993;Guo et al., 1994). However, all these recombinant viruses are able to replicate in target birds and the risk of horizontal spreading of such recombinant viruses remains to be assessed.Use of replication-defective viruses can be a way to combine biosafety and efficiency. Canarypox viruses (Taylor et al., 1992) and replication-defective adenoviruses have been shown to efficiently overcome protective immunity in mammalian species. Recombinant replication-defective adenoviruses are constructed by deleting the EIA or the E1A/E1B genes in such a way that the viral cycle is blocked in the early phase. (Oualikene et al., 1994). These kinds of viruses are currently being studied as viral vectors for gene therapy and for vaccination purposes. Some properties of these viruses are very promising (for a review, see Ali et al., 1994): first, adenoviruses are able to introduce foreign genes into a wide spectrum of cells including muscle, epithelial, neuronal and macrophage cells; secondly, viral DNA is maintained mainly as an episome for several weeks or even months, the transduced gene being expressed during this time in such a way that a longlasting immune response can be expected. Moreover, despite its human origin, this virus is able to target foreign genes in a wide range of animal species, even those in which adenovirus type 5 (Ad5) cannot replicate. Dogs, cattle (Prevec et a...